We recently published a list of 10 Firms End Friday Strong; 3 Reach All-Time Highs. In this article, we are going to take a ...

Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit convinced a federal appeals court Mylan Laboratories Ltd.’s planned ...

Milestone in 2023 agreed to sell a royalty interest in etripamil to RTW Investments for $75 million, subject to the company receiving FDA approval of the drug by the end of September 2025. Write to ...

Mylan has been in the news for hiking prices on its EpiPen. The stock is flat since we recommended it in March, but we now ...

The Dow Jones Industrial Average moved off lows with the other major stock indexes in the stock market today on "quadruple ...

Detailed price information for Jazz Pharma Plc (JAZZ-Q) from The Globe and Mail including charting and trades.

Can Nvidia Corp.’s “brutalized” stock meaningfully turn things around? Shares of Nvidia — and Broadcom Inc., for that matter — “are looking attractive for those who can wait out the ...

Chardan Capital dropped their target price on Rocket Pharmaceuticals from $62.00 to $54.00 and set a “buy” rating on the stock in a report on Friday, February 28th. Leerink Partners dropped ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

NEW YORK--(BUSINESS WIRE)--Nussbaum Law Group, P.C. and Roberts Law Firm US, PC: A proposed settlement (“Settlement”) has been reached in a class action lawsuit alleging that Mylan N.V., Mylan ...